ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Minnesota » Internal Medicine

Top Internal Medicine Prescribers in Minnesota

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
JOHN LADWIG MD

Internal Medicine

27,735

$1.48M

955
857 are 65+

5%
patients receiving schedule two controlled substances

Avg: 5%

13%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 22%

$54
Average prescription price

Avg: $58

BRUCE MONEY MD

Internal Medicine

23,145

$1.19M

963
886 are 65+

6%
patients receiving schedule two controlled substances

Avg: 5%

6%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 22%

$51
Average prescription price

Avg: $58

SANJAY PATEL MD

Internal Medicine

18,728

$1.01M

891
810 are 65+

3%
patients receiving schedule two controlled substances

Avg: 5%

10%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 22%

$54
Average prescription price

Avg: $58

ARVIN VOCAL M.D.

Internal Medicine

17,664

$949K

675
588 are 65+

6%
patients receiving schedule two controlled substances

Avg: 5%

7%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 22%

$54
Average prescription price

Avg: $58

ERIC STORVICK MD

Internal Medicine

17,649

$1.01M

753
677 are 65+

8%
patients receiving schedule two controlled substances

Avg: 5%

9%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 22%

$57
Average prescription price

Avg: $58

ALAN DIVINE M.D.

Internal Medicine

17,545

$1.08M

658
599 are 65+

9%
patients receiving schedule two controlled substances

Avg: 5%

12%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 22%

$61
Average prescription price

Avg: $58

MIKHAIL PERELMAN MD

Internal Medicine

16,818

$802K

354
312 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

10%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 22%

$48
Average prescription price

Avg: $58

FRANKLIN FLEMING MD

Internal Medicine

16,582

$1.04M

745
679 are 65+

12%
patients receiving schedule two controlled substances

Avg: 5%

14%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 22%

$63
Average prescription price

Avg: $58

MARY CAMERON MD

Internal Medicine

16,243

$770K

700
636 are 65+

9%
patients receiving schedule two controlled substances

Avg: 5%

9%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

16%
prescriptions for brand name drugs

Avg: 22%

$47
Average prescription price

Avg: $58

STEPHEN HANSKE MD

Internal Medicine

16,220

$971K

739
649 are 65+

5%
patients receiving schedule two controlled substances

Avg: 5%

8%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 22%

$60
Average prescription price

Avg: $58

THEODORE OLSON MD

Internal Medicine

15,732

$837K

507
463 are 65+

6%
patients receiving schedule two controlled substances

Avg: 5%

10%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 22%

$53
Average prescription price

Avg: $58

ASHOK PATEL MD

Internal Medicine

15,344

$805K

520
487 are 65+

4%
patients receiving schedule two controlled substances

Avg: 5%

7%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 22%

$52
Average prescription price

Avg: $58

GREGORY CLARK MD

Internal Medicine

15,196

$707K

741
654 are 65+

2%
patients receiving schedule two controlled substances

Avg: 5%

5%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 22%

$47
Average prescription price

Avg: $58

KATRINA HAMMEL M.D.

Internal Medicine

15,014

$698K

586
471 are 65+

11%
patients receiving schedule two controlled substances

Avg: 5%

11%
patients receiving schedule three controlled substances

Avg: 6%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 22%

$46
Average prescription price

Avg: $58

MARITZA LOPEZ M.D.

Internal Medicine

14,990

$922K

356
319 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

4%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

30%
prescriptions for brand name drugs

Avg: 22%

$62
Average prescription price

Avg: $58

SUSAN MARK M.D.

Internal Medicine

14,838

$518K

613
485 are 65+

6%
patients receiving schedule two controlled substances

Avg: 5%

10%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

17%
prescriptions for brand name drugs

Avg: 22%

$35
Average prescription price

Avg: $58

ABRAHAM JOSEPH MD

Internal Medicine

14,454

$670K

761
648 are 65+

7%
patients receiving schedule two controlled substances

Avg: 5%

5%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 22%

$46
Average prescription price

Avg: $58

RICHARD SUDMEIER MD

Internal Medicine

14,383

$716K

832
708 are 65+

2%
patients receiving schedule two controlled substances

Avg: 5%

6%
patients receiving schedule three controlled substances

Avg: 6%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 22%

$50
Average prescription price

Avg: $58

FREDERICK TOWNSEND MD

Internal Medicine

14,167

$828K

619
558 are 65+

4%
patients receiving schedule two controlled substances

Avg: 5%

11%
patients receiving schedule three controlled substances

Avg: 6%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 22%

$58
Average prescription price

Avg: $58

WAI LUN CHAN MD

Internal Medicine

14,025

$588K

460
392 are 65+

7%
patients receiving schedule two controlled substances

Avg: 5%

6%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 22%

$42
Average prescription price

Avg: $58

RODNEY WILL MD

Internal Medicine

13,901

$818K

576
507 are 65+

4%
patients receiving schedule two controlled substances

Avg: 5%

6%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 22%

$59
Average prescription price

Avg: $58

ASHOK OJHA M.D.

Internal Medicine

13,848

$605K

517
480 are 65+

4%
patients receiving schedule two controlled substances

Avg: 5%

10%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

15%
prescriptions for brand name drugs

Avg: 22%

$44
Average prescription price

Avg: $58

PAUL BROWN M.D.

Internal Medicine

13,764

$510K

584
530 are 65+

7%
patients receiving schedule two controlled substances

Avg: 5%

16%
patients receiving schedule three controlled substances

Avg: 6%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

16%
prescriptions for brand name drugs

Avg: 22%

$37
Average prescription price

Avg: $58

DONALD DEYE MD, FACP

Internal Medicine

13,456

$684K

514
429 are 65+

8%
patients receiving schedule two controlled substances

Avg: 5%

13%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 22%

$51
Average prescription price

Avg: $58

MICHAEL SAND DO

Internal Medicine

13,444

$724K

699
618 are 65+

3%
patients receiving schedule two controlled substances

Avg: 5%

6%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 22%

$54
Average prescription price

Avg: $58

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank